Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

By Tzavara E.T.   Perry K.W.   Rodriguez D.E.   Bymaster F.P.   Nomikos G.G.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the reinforcing effects of the cannabinoid CB 1 receptor antagonist, SR141716, in rhesus monkeys

By Beardsley P.M.   Dance M.E.   Balster R.L.   Munzar P.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB 1 receptor antagonist, SR 141716

By Vacca G.   Serra S.   Brunetti G.   Carai M.A.M.   Gessa G.L.   Colombo G.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite